Latest Cancer: Leukemia news
Ivosidenib + Azacitidine Ups Event-Free Survival in IDH1-Mutated AML
posted April 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
AACR: Novel COVID-19 Vaccine Aimed at Immunocompromised Patients
posted April 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
AACR: Resistance Mechanisms to CAR-T Cell Therapy ID’d in ALL
posted April 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Survival Up With Bortezomib in T-Cell Lymphoblastic Lymphoma
posted March 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Azacitidine + Venetoclax Tied to Improved Event-Free Survival in Adults With AML 
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally Monthly Specialist Briefings
Stay Connected
